Available online - the Spotlight "FN3K: the (un)sweetest kinase" from Viraj Sanghvi @oncolab.bsky.social and colleagues. #ProteinPhosphorylation #ProteinGlycation #AdvancedGlycationEndProducts #AGE #SBDD Read it here: authors.elsevier.com/a/1ktQO3S6Gf...

Big thanks to Viraj for the lovely and thoughtful write-up on our collaboration with Leemor! And major shoutout to Yang from my lab for the gorgeous biochemistry—so proud! ✨👏🧪

Check out our article in @cp-trendsbiochem.bsky.social highlighting the elegant work by Joshua-Tor lab, @davidlabmsk.bsky.social, and team .Their findings shed light on the structural basis of FN3K function and open doors for targeting glycation-related diseases. @sanniejculbertson.bsky.social

This is dangerously irresponsible on every level. Indiscriminately slashing this funding will cripple lifesaving research on everything from cancer to opioid addiction.

Congratulations to @obenaufa.bsky.social and the whole team for this very exciting story on immune suppression in cancer

“NIH produces an astounding return on investment to the American taxpayer. In Fiscal Year 2022, NIH research funding supported 568,585 jobs and generated $96.84 billion in economic activity — that’s $2.64 of economic activity for every $1 of research funding.” www.researchamerica.org/2023-oped-us...

Are you Interested in researching liver cancer or post-translational modifications - our group at Columbia University is expanding and we are looking for motivated postdocs www.linkedin.com/jobs/view/40...

We are looking for a postdoctoral data scientist position to join our supportive and fun group :) Join us @QMBCI in vibrant #London to delve into the analysis of repetitive genome in #cancer! We support for visa applications, career and personal development! www.jobs.ac.uk/job/DFN649/p...